Larsson L I
Histochemistry. 1985;82(2):121-30. doi: 10.1007/BF00708195.
Immunocytochemical quantitative studies on the development of rat thyroid calcitonin (C) cells have been performed. In neonatal rat pups up to day 6 nearly 90% of all calcitonin cells are also somatostatin immunoreactive and 45% of these cells also show immunoreactivity to a C-terminal gastrin/cholecystokinin antiserum (CCK-4-like immunoreactivity). Already at day 8 the frequency of somatostatin immunoreactive calcitonin cells has dropped to 25%, whereas half of the calcitonin cells still display CCK-4-like immunoreactivity. In adult rats, less than 1% of the calcitonin cells are somatostatin immunoreactive, whereas 90% of the calcitonin cells display CCK-4-like immunoreactivity. These data show that between day 6-8 a pronounced change in the peptide repertoire of rat thyroid C cells occur and that these cells, prior to this time, mainly contain calcitonin and somatostatin immunoreactivity and after this time mainly contain calcitonin and CCK-4-like immunoreactivity. The time course of the change in the C cell peptides is similar to that observed with changes in transitory peptides of neonatal rat pancreas and duodenum, suggesting that possible hormonal mechanisms during this period act to change the peptide repertoire of several endocrine cell types simultaneously. It is possible that many of the transitory peptides exert actions in the developing individual that are necessary for growth and differentiation. Interestingly, many of these transitory peptides reappear in tumours, where theoretically they could exert similar actions.
已对大鼠甲状腺降钙素(C)细胞发育进行了免疫细胞化学定量研究。在出生后6天内的新生大鼠幼崽中,几乎所有降钙素细胞的90%也有生长抑素免疫反应性,其中45%的细胞对C末端胃泌素/胆囊收缩素抗血清也有免疫反应性(CCK - 4样免疫反应性)。在第8天,有生长抑素免疫反应性的降钙素细胞频率已降至25%,而一半的降钙素细胞仍显示CCK - 4样免疫反应性。在成年大鼠中,不到1%的降钙素细胞有生长抑素免疫反应性,而90%的降钙素细胞显示CCK - 4样免疫反应性。这些数据表明,在第6 - 8天期间,大鼠甲状腺C细胞的肽谱发生了显著变化,并且在此之前,这些细胞主要含有降钙素和生长抑素免疫反应性,在此之后主要含有降钙素和CCK - 4样免疫反应性。C细胞肽变化的时间进程与新生大鼠胰腺和十二指肠中瞬时肽变化所观察到的相似,这表明在此期间可能的激素机制作用于同时改变几种内分泌细胞类型的肽谱。许多瞬时肽可能在发育中的个体中发挥对生长和分化必需的作用。有趣的是,许多这些瞬时肽在肿瘤中重新出现,理论上它们在肿瘤中可能发挥类似作用。